Chicago-Kent’s 1L Your Way Program allows students who know the area of law in which they would like to specialize to select a more flexible track. This optional program allows full-time J.D. students to defer a required first-year course to the second year in favor of taking either an approved, upper-division elective course or a unique first-year clinical course.
IL Your Way enhances students’ ability to exercise agency over their own education—which, literature suggests, has substantial pedagogical benefits—while also ensuring that all students are exposed to the necessary building blocks of the law. Elective Course Option. For example, students interested in intellectual property may take Patent Law, which would allow them to take the Patent Bar during their second year. Similarly, students who know they want to specialize in labor and employment law may take Employment Relationships, and students who plan to practice in a corporate law environment may take Business Organizations. The law school hopes this flexibility enhances students’ marketability for summer employment.
Legal Clinic Option. Instead of taking an elective, students may choose to participate in one of the law school’s clinics to gain a better sense of the skills demanded in practice areas of interest to the student. Clinic practice areas at Chicago-Kent include criminal defense, employment/civil litigation, entrepreneurial law, family law, health and disability law, and tax and probate law.
Students also can opt into a rotation option for their 1L clinic options. Loosely based on the medical school model, this opportunity allows first-year students to participate along with upper level students as members of more than one clinic.
As a result of this new program, in spring 2019, Chicago-Kent College of Law became one of the few law schools to allow first-year students to fully participate in the law school’s clinics. The law school anticipates that approximately 50 Chicago-Kent 1L students will be eligible to participate in the First-Year Clinic during the spring semester each year.







Studies done on the error rates of cancer diagnosis has found that as much as 1 in 4 suffers from inadequate physical examinations and incomplete diagnostic tests. AI will fix this! AI will soon be able to be linked to tools that are able to analyze compounds in the human breath, detecting illnesses like cancer. AI tools have been and will continue to be trained with data from patients with various types of cancers. Cancers produce a distinctive smell of volatile organic compounds. AI will one day be able to decipher through normal chemical compounds in breath samples to identify those being emitted by the tumor. AI detection tools will not be used to replace physicians, but rather it will function as a supportive tool to help confirm their conclusions. The AI tool will be able to take minutes to autonomously analyze a breath sample that traditionally takes physicians hours to analyze.
of toxicities or metastasis. Therefore, there is an increasing need to develop strategies for determining appropriate doses and dosing windows. There are many factors that affect the pharmacokinetics of detecting an appropriate dose or dosing window including ethnicity, age, gender, concomitant medication, and weight. AI could be used to investigate the clinical and genetic factors significantly associated with the appropriate dosing and timing.
AI in combination with blockchain and the Internet of Things will help patients to play a more active role in their health. Patients will soon have their records stored on a single platform for all of their doctors to access when diagnosing and prescribing medication. Patients will soon be able to leverage IoT tools to help monitor their glucose levels and heart rates, allowing for patients to respond to potential issues earlier. By having the power in their fingertips, patients can obtain reliable second and third opinions by granting access to all of their medical records in Realtime.